2.455
Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
22.39%
4.349
|
5.604 | 4.015 | 3.754 | 3.564 |
| Cost Of Revenue |
22.53%
2.699
|
3.484 | 2.551 | 2.226 | 2.294 |
| Gross Profit |
22.17%
1.65
|
2.12 | 1.464 | 1.528 | 1.27 |
|
|
5.25%
2.328
|
2.457 | 2.559 | 2.184 | 2.301 |
| Benefits Costs and Expenses |
16.37%
5.298
|
6.335 | 5.257 | 4.282 | 4.483 |
| Costs And Expenses |
16.37%
5.298
|
6.335 | 5.257 | 4.282 | 4.483 |
| Operating Income/Loss |
101.19%
-0.678
|
-0.337 | -1.095 | -0.656 | -1.031 |
| Income/Loss From Continuing Operations Before Tax |
29.82%
-0.949
|
-0.731 | -1.242 | -0.528 | -0.919 |
| Income Tax Expense/Benefit |
34.01%
-0.13
|
-0.197 | -0.001 | 0.248 | 0.009 |
| Income/Loss From Continuing Operations After Tax |
53.37%
-0.819
|
-0.534 | -1.241 | -0.776 | -0.928 |
|
|
53.37%
-0.819
|
-0.534 | -1.241 | -0.229 | -0.928 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | 0.547 | - |
| Basic Average Shares |
4.07%
1.713
|
1.646 | 1.641 | 0.124 | 1.464 |
| Diluted Average Shares |
4.07%
1.713
|
1.646 | 1.641 | 0.124 | 1.464 |
| Basic Earnings Per Share |
50.00%
-0.48
|
-0.32 | -0.76 | -0.39 | -0.63 |
| Diluted Earnings Per Share |
50.00%
-0.48
|
-0.32 | -0.76 | -0.39 | -0.63 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):